Found 2958 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)
PHASE1Primary trial objective in this single arm trial is to assess the safety an...
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
PHASE3This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Location
Harbin Medical University Cancer Hospital
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PHASE1This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma
PHASE2This is an open-label, Phase II interventional study in order to assess eff...
Location
University of Colorado Hospital
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1
PHASE2This is a single-center, prospective, single-arm, open-label phase II study...
Location
Asan Medical Center
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
EARLY_PHASE1Background:
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymph...
Location
National Institutes of Health Clinical Center
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore
PHASE2This is a single-arm, open-label, multi-center clinical study to evaluate t...
Location
Nanfang Hospital, Southern Medical University
A Multi-centre, Double-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR
PHASE4Anterior cruciate ligament (ACL) is the key ligament connecting the femur t...
Location
Prince of Wales Hospital
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
PHASE1The first testing of TargomiRs in the human setting: dose-finding studies i...
Location
Concord Repatriation General Hospital